• slider-dummy-1.jpg
  • image3.jpg
  • image4.jpg

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values


EGA and EBG welcome a new milestone in the EU Biosimilars medicines regulatory framework

October 30, 2014

The EGA and the European Biosimilars Group (EBG), a sector group of the EGA, congratulate the EMA and its Committee for Medicinal Products for Human Use (CHMP) and Biosimilar Medicines Working Party (BMWP) for adopting its revised overarching guideline on biosimilar medicines.


Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about careers at Sandoz

Watch our Sandoz TV video series to discover more about the world of Sandoz and generics.

Visit our multimedia gallery to watch the latest episode



We have collected the most important and frequently asked questions about our business.

Visit our frequently asked questions page